Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Barbara
Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Primary Extranodal Follicular Lymphoma: A Retrospective Survey of the International Extranodal Lymphoma Study Group (IELSG)
Conflicts of Interest The authors declare no conflicts of interest. References 1, , , et al., “Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study,” Journal of Clinical Oncology 33, no. 23 (August 2015): 2516–2522, https://doi.org/10.1200/JCO.2014.59.7534.
A phase II trial of bendamustine in combination with ofatumumab in patients with relapsed or refractory marginal zone B‐cell lymphomas
ORIGINAL RESEARCH ARTICLE Anastasios Stathis Corresponding Author E-mail address: anastasios.stathis@eoc.ch Oncology Institute of Southern Switzerland, (IOSI) Bellinzona, Switzerland Faculty of Biomedical Sciences, USI, Lugano, Switzerland Correspondence PD Dr. med. Anastasios Stathis, Oncology Institute of Southern Switzerland, (IOSI) Ospedale San Giovanni 6500 Bellinzona Switzerland.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Barbara
Contact Barbara, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack